Park Ha Biological Technology Co., Ltd. (PHH)
| Market Cap | 131.00M |
| Revenue (ttm) | 1.94M |
| Net Income (ttm) | 401,146 |
| Shares Out | 26.20M |
| EPS (ttm) | 0.02 |
| PE Ratio | 326.56 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PHH
Park Ha Biological Technology specializes in providing skincare and cosmetic products under the brand name “Park Ha” in China. Our Operating Subsidiaries develop our proprietary beauty products and offer complimentary after-sales beauty services in our physical stores. Park Ha Jiangsu, in addition to operating our two physical stores, is the research and development center focusing on skincare products development and improvement for sensitive skin. Xinzhan leads the marketing and promotional efforts and is the entity in charge of our franchisi... [Read more]
News
Park Ha Biological Aims For U.S. IPO At Sky-High Valuation
Park Ha Biological Technology Co., Ltd. seeks $6 million in an IPO, but has wildly excessive valuation expectations given its small size and fluctuating financial metrics. The company faces numerous r...
U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market
While major IPOs are on hold until after Labor Day, three small deals were completed in the last week of August. Two SPACs, GigCapital7 and Black Spade Acquisition II, raised $200 million and $150 mil...
Chinese skincare product company Park Ha Biological Technology files and sets terms for a $7 million US IPO
Park Ha Biological Technology, which sells skincare and cosmetic products in China, filed on Monday with the SEC to raise up to $7 million in an initial public offering.
Park Ha Biological Technology IPO Registration Document (F-1)
Park Ha Biological Technology has filed to go public with an IPO on the NASDAQ.